Document is current
Any future updates will be listed below
-
Authors
Pattanayak, Shakti P
Darawshi, Odai
Hajihassani, Omid
Winter, Jordan M
Weiler, Nicole
Ott, Melanie
Rothweiler, Florian
Cinatl, Jindrich Jr.
Michaelis, Martin
Lindner, Daniel J
Green, Thomas D
Krassovskaia, Polina
Aruleba, Raphael T
Fisher-Wellman, Kelsey H
Mears, Jason A
Wald, David
Eriksson, Leif A
Tirosh, Boaz
-
Funding
Funding for this research was provided by:
National Institutes of Health (1R01CA299332)
International Myeloma Foundation (Brian D. Novis Senior Award)
Council of Advanced Human Health
Case Technology Validation and Startup Fund Program
- License Information
-
More Information
Article History
Received: 13 April 2026
Accepted: 11 May 2026
First Online: 27 May 2026
Declarations
:
: The protocol of the mice study was reviewed and approved (IACUC protocol number# 2023-0013) by the Institutional Animal Care and Use Committee (IACUC) of Case Western Reserve University.
: Not applicable.
: A patent for AcTor has been filed. Inventors are BT, SPP, DW and LAE.
